Hyponatremia screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Saeedeh Kowsarnia M.D.[2]
Overview
Overview
Hyponatremia is the most common electrolyte disturbances which are common with certain medical conditions and drugs. Screening the hyponatremia is necessary for preventing further decrease in serum sodium and complications of treatment.
Screening
Screening
Plasma sodium should be check in
- 1–2 weeks after initiation of thiazide, SNRI, and SSRI therapy, especially in patients at high risk for hyponatremia [1][2]
- All hospitalized patients on admission
- Check plasma level daily in all patients with hyponatremia
- Check plasma level in all patients with risk of hyponatremia
To see the risk factors for developing hyponatremia, click here.
References
References
- ↑ T. J. Wilkinson, E. J. Begg, A. C. Winter & R. Sainsbury (1999). “Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people”. British journal of clinical pharmacology. 47 (2): 211–217. PMID 10190657. Unknown parameter
|month=ignored (help) - ↑ K. M. Chow, C. C. Szeto, T. Y.-H. Wong, C. B. Leung & P. K.-T. Li (2003). “Risk factors for thiazide-induced hyponatraemia”. QJM : monthly journal of the Association of Physicians. 96 (12): 911–917. PMID 14631057. Unknown parameter
|month=ignored (help)
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH